Evaluation of Safety and Activity of an Anti-PDL1 Antibody (DURVALUMAB) Combined With CSF-1R TKI (PEXIDARTINIB) in Patients With Metastatic/Advanced Pancreatic or Colorectal Cancers
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Advanced Cancer
Related studies linked through entity extraction aliases.
An Investigational Immuno-therapy Study to Test Combination Treatments in Patients With Advanced Non-Small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Lucitanib (E3810) in Patients With Advanced Cancer and FGFR, VEGFR, or PDGFR Pathway Aberrations
- Status
- WITHDRAWN
- Phase
- PHASE2
A Study in Advanced Cancers Using Ramucirumab (LY3009806) and Other Targeted Agents
- Status
- COMPLETED
- Phase
- PHASE1
An Investigational Immuno-therapy Study of Nivolumab or Placebo in Participants With Resected Esophageal or Gastroesophageal Junction Cancer
- Status
- COMPLETED
- Phase
- PHASE3
An Investigational Immuno-Therapy Study of Experimental Medication BMS-986178 by Itself or in Combination With Nivolumab and/or Ipilimumab in Participants With Solid Cancers That Are Advanced or Have Spread
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Primary Palliative Care Intervention for Patients With Advanced Cancer
- Status
- COMPLETED
- Phase
- NA
A Study of Ramucirumab (LY3009806) or Merestinib (LY2801653) in Advanced or Metastatic Biliary Tract Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Safety and Pharmacokinetic Study of TRX-818 in Asian Solid Tumor Patients
- Status
- COMPLETED
- Phase
- PHASE1
Study to Evaluate PM01183 in Combination With Olaparib in Advanced Solid Tumors
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
A Study of Safety, Pharmacokinetics, Pharmacodynamics of JNJ-61610588 in Participants With Advanced Cancer
- Status
- TERMINATED
- Phase
- PHASE1
Online Information and Support for Distance Caregivers
- Status
- COMPLETED
- Phase
- NA
An Investigational Immuno-therapy Study of BMS-986205 Given in Combination With Nivolumab and in Combination With Both Nivolumab and Ipilimumab in Cancers That Are Advanced or Have Spread
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Transcutaneous Electrical Nerve Stimulation (TENS) for Advanced Cancer Pain Patients
- Status
- COMPLETED
- Phase
- NA
A Study to Evaluate the Safety and Pharmacokinetics of CDX-0158 in Adult Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Randomized Controlled Trial of the Meaning-Making Intervention (MMi) In Newly Diagnosed Advanced Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Pharmacokinetics of Systemic Anti-Cancer Therapies in the Cerebrospinal Fluid (CSF) of Patients With Advanced Cancer
- Status
- TERMINATED
- Phase
- N/A
A Study Of Avelumab In Combination With Other Cancer Immunotherapies In Advanced Malignancies (JAVELIN Medley)
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A Study of LY3076226 in Participants With Advanced or Metastatic Cancer
- Status
- COMPLETED
- Phase
- PHASE1